ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon chief bats for dual-agency model to fast-track drug approvals
Biocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews for new drugs and devices. The Central Drugs Standard Control Organisation would then grant final regulatory approval.
Announcement as on 23 November 2025

Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-Shaw
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to accelerate growth in the biologics space. The company is uniquely positioned with interchangeable biosimilar insulins and aims to
Announcement as on 21 November 2025

Biocon considers merging Biocon Biologics in .5 billion deal; IPO and share swap options under review
Biocon is exploring merging its biosimilars arm, Biocon Biologics, with itself, potentially valuing the unit at .5 billion. The company is in advanced talks with minority investors for a share swap, considering various value creation options including an
Announcement as on 13 November 2025

Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Biocon Group reported a strong Q2 FY26 with a 20% year-on-year increase in operating revenue to Rs 4,296 crore, driven by biosimilars and generics. Net profit surged 428% to Rs 85 crore, boosted by debt settlement and strategic partnerships for affordable
Announcement as on 11 November 2025

Biocon unit gets USFDA nod for genetic anti-bacterial drug
Biocon's unit, in partnership with Carnegie Pharmaceuticals, has secured tentative approval from the USFDA for Rifaximin Tablets. This genetic anti-bacterial medication is used to reduce the risk of hepatic encephalopathy recurrence and treat irritable bow
Announcement as on 07 October 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 361.37
  • 12Day Average: 358.38
  • 20Day Average: 354.41
  • 50Day Average: 370.98
  • 100Day Average: 375.74
  • 150Day Average: 375.45
  • 200Day Average: 374.21

532523 Indicators & signals

Indicator MACD (12,26,9)

358.74, 360.9, -3.96
Indicator MACD is in negative zone

Indicator ADX (14)

9.91, 20.08, 24.5
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 41
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Mon May 2026 360.40 359.75 to 366.20 0.24% 0.89 times
30 Thu Apr 2026 359.55 354.80 to 361.55 -0.76% 0.93 times
29 Wed Apr 2026 362.30 361.40 to 368.25 -0.14% 0.91 times
28 Tue Apr 2026 362.80 359.25 to 365.45 0.28% 1.2 times
27 Mon Apr 2026 361.80 350.55 to 362.50 3.47% 1.08 times
24 Fri Apr 2026 349.65 348.50 to 358.80 -2.28% 0.99 times
23 Thu Apr 2026 357.80 355.80 to 364.70 0.04% 0.88 times
22 Wed Apr 2026 357.65 356.30 to 363.70 -1.04% 0.88 times
21 Tue Apr 2026 361.40 359.00 to 364.60 0.81% 0.73 times
20 Mon Apr 2026 358.50 355.00 to 362.50 0.08% 1.52 times
17 Fri Apr 2026 358.20 349.55 to 358.65 2.18% 0.88 times
16 Thu Apr 2026 350.55 346.95 to 354.90 0.03% 1.24 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top